Invenomic Capital Management LP Fulgent Genetics, Inc. Transaction History
Invenomic Capital Management LP
- $1.73 Billion
- Q2 2025
A detailed history of Invenomic Capital Management LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 31,125 shares of FLGT stock, worth $653,936. This represents 0.04% of its overall portfolio holdings.
Number of Shares
31,125
Previous 236,172
86.82%
Holding current value
$653,936
Previous $3.99 Million
84.52%
% of portfolio
0.04%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding FLGT
# of Institutions
189Shares Held
18.4MCall Options Held
185KPut Options Held
24.8K-
Black Rock Inc. New York, NY3.92MShares$82.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.44MShares$30.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$24.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$23.8 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.12MShares$23.5 Million0.05% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $636M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...